A Taiwan-developed Chinese medicine formula used alongside Western medicine to treat COVID-19 patients could be approved for use in Taiwan as early as this week, according to a senior official at the Ministry of Health and Welfare (MOHW).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Formosa Smart Energy partners with Polish group on new energy projects
07/02/2025 03:16 PM - Business
Taipei Fubon Bank secures FSC approval to open branch in India
07/02/2025 03:05 PM - Politics
Senior KMT official detained in Pingtung recall forgery case
07/02/2025 02:01 PM - Business
Taiwan shares close up 0.11%
07/02/2025 01:54 PM - Business
Stock trading accounts hit new high despite U.S. tariff concerns
07/02/2025 12:47 PM